Trial intelligence / Profile preview

Quantification of Diclofenac 2.32% in Rinse Water After Different Application Methods

NCT06954181Completed

Sponsor
Haleon
Start
Mar 2025
Primary completion
Apr 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of diclofenac in pain (3 arms), sponsored by Haleon. Primary endpoints: Concentration of Voltaren Schmerzgel Forte; 2.32% (Diclofenac) in Water at Day 5 and Amount of Test Product Residues by Gravimetrical Measurements at Day 5. Started Mar 2025; status: completed.

02

Drugs

diclofenac
03

Conditions

pain

Beyond the preview

Go deeper on NCT06954181.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06954181.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call